Leona A Holmberg
Overview
Explore the profile of Leona A Holmberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Georges G, Khanna D, Wener M, Mei M, Mayes M, Simms R, et al.
Arthritis Rheumatol
. 2024 Dec;
PMID: 39624016
Objective: Two randomized trials for patients with diffuse systemic sclerosis (SSc) demonstrated an overall survival (OS) and event-free survival (EFS) advantage of autologous hematopoietic stem cell transplantation (AHSCT) using CD34+...
2.
Holmberg L, Maloney D, Connelly-Smith L
Acta Haematol
. 2023 Sep;
147(3):300-309.
PMID: 37708877
Introduction: The success of autologous stem cell transplantation (ASCT) for treating non-Hodgkin's lymphoma (NHL) is limited by its high relapse rates. To reduce the risk of relapse, additional maintenance therapy...
3.
Ragon B, Shah M, DSouza A, Estrada-Merly N, Gowda L, George G, et al.
Blood Adv
. 2023 Feb;
7(12):2746-2757.
PMID: 36827681
The overall survival (OS) has improved significantly in multiple myeloma (MM) over the last decade with the use of proteasome inhibitor and immunomodulatory drug-based combinations, followed by high-dose melphalan and...
4.
Minnie S, Waltner O, Ensbey K, Olver S, Collinge A, Sester D, et al.
J Clin Invest
. 2022 Dec;
133(4).
PMID: 36512425
Autologous stem cell transplantation (ASCT) with subsequent lenalidomide maintenance is standard consolidation therapy for multiple myeloma, and a subset of patients achieve durable progression-free survival that is suggestive of long-term...
5.
Kosydar S, Gulhane A, Libby E, Cowan A, Kwok M, Lee S, et al.
Am J Clin Oncol
. 2022 Nov;
45(11):443-449.
PMID: 36346953
Objective: Although recurrence rates after radiotherapy for solitary plasmacytoma (SP) are well established, little is known about how SP responds radiographically, as most historical patients were treated in the 2D...
6.
Holmberg L, Linenberger M, Connelly-Smith L
Transplant Cell Ther
. 2022 Aug;
28(11):754-759.
PMID: 36002104
A major barrier for proceeding to autologous stem cell transplantation (ASCT) is an inability to mobilize and collect an adequate number of peripheral blood (PB) stem cells (PBSC) for the...
7.
Cowan A, Green D, Kwok M, Lee S, Coffey D, Holmberg L, et al.
JAMA
. 2022 Feb;
327(5):464-477.
PMID: 35103762
Importance: Multiple myeloma is a hematologic malignancy characterized by presence of abnormal clonal plasma cells in the bone marrow, with potential for uncontrolled growth causing destructive bone lesions, kidney injury,...
8.
Cowan A, Stevenson P, Green D, Tuazon S, Libby E, Kwok M, et al.
Transplant Cell Ther
. 2021 Apr;
27(8):661.e1-661.e6.
PMID: 33895403
Since the introduction of lenalidomide into induction therapy for multiple myeloma (MM), there have been conflicting reports about its impact on autologous peripheral blood stem cell (PBSC) mobilization. We evaluated...
9.
Tuazon S, Holmberg L, Nadeem O, Richardson P
Blood Cancer J
. 2021 Feb;
11(2):23.
PMID: 33563906
Primary plasma cell leukemia (pPCL) is an aggressive plasma cell disorder with a guarded prognosis. The diagnosis is confirmed when peripheral blood plasma cells (PCs) exceed 20% of white blood...
10.
Bonm A, Gibson A, Holmberg L, Mielcarek M, McGranahan T, Taylor L, et al.
J Neurooncol
. 2021 Jan;
151(2):193-200.
PMID: 33398532
Background: Relapsed or refractory primary CNS lymphoma (rrPCNSL) is a rare and challenging malignancy for which better evidence is needed to guide management. Methods: We present a retrospective cohort of...